Paola Donaji Contreras Pineda

PhD student at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Magnus Essand

E-mail:: paola.contreras@igp.uu.se
Visiting address:: Dag Hammarskjölds väg 20
751 85 Uppsala
Postal address:: Rudbecklaboratoriet
751 85 UPPSALA

Download contact information for Paola Donaji Contreras Pineda at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Magnus Essand

Publications

Recent publications

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas

Ma, Jing; Sarén, Tina; Jin, Chuan; Kim, Hyeong Su et al.

Part of Cancer Immunology and Immunotherapy, 2025
- DOI for Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
- Download full text (pdf) of Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response

Ali, Arwa; Contreras, Paola; Darweesh, Mahmoud; Andersson, Leif et al.

Part of Molecular Therapy Nucleic Acids, 2024
- DOI for Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
- Download full text (pdf) of Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response

All publications

Articles in journal

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas

Ma, Jing; Sarén, Tina; Jin, Chuan; Kim, Hyeong Su et al.

Part of Cancer Immunology and Immunotherapy, 2025
- DOI for Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
- Download full text (pdf) of Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response

Ali, Arwa; Contreras, Paola; Darweesh, Mahmoud; Andersson, Leif et al.

Part of Molecular Therapy Nucleic Acids, 2024
- DOI for Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
- Download full text (pdf) of Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response